Lumen Bioscience
Kole’s in-depth experience and vast network within the biotech and pharmaceutical industry is perfectly aligned to his role of Vice President of Business Development at Lumen Bioscience. Prior to joining Lumen, Kole was the Vice President of Business Development for Absci Bio (NASDAQ:ABSI), a publicly traded AI drug and target discovery company utilizing synthetic biology. While at Absci, Kole led business development and sales efforts. During his five-year tenure, he created long-term partnerships with biotech and pharma companies that resulted in multiple historic licensing deals, enabling the growth of the company from 15 to 250+ employees. In 2019, Kole was selected by the Portland Business Journal as the region’s ‘Rainmaker’, an award given to the top business sales professional.
This person is not in any teams
Lumen Bioscience
Lumen unlocks the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. Lumen's goal is to transform the way such drugs are developed, what they cost, and who has access to them.